Genetic testing is becoming more and more important day by day as it may reveal the potential health risks that general testing may not.
Genetic testing is becoming more and more important day by day as it may reveal the potential health risks that general testing may not. Health conditions involving heart failure and sudden heart attack can be predicted with such testing approach. According to the report from the Sudden Arrhythmia Death Syndromes (SADS) Foundation, nearly 49% of the victims of sudden cardiac death had family history that might have triggered diagnostic testing. In addition, cascade genetic testing outlined that an average of 8.9 additional family members can be affected with such condition.
This report outlined the importance of genetic testing in cardiology. Leading market players and laboratories formed the alliance to raise awareness. Heart disease is the most common cause of mortality in the world. Genetic testing can be utilized for determining the patients at risk before various heart conditions occur in them. Researchers have been conducting trials and determining potential heart diseases based on DNA makeup. According to the report published by Allied Market Research, the global genetic testing market is estimated to reach $21.26 billion by 2027. Following are some of the activities taking place across the world.
Laboratories, market players, and research institutes have realized the need to increase the awareness regarding genetic testing. They formed alliance that would work toward surging awareness across the world. GeneDx, Illumina, Invitae, Fulgent Genetics, and PerkinElmer Genomics formed an alliance named CardioGenomic Testing Alliance (CGTA) for raising awareness about genetic testing in cardiology. This alliance is aimed at creating awareness about the testing at healthcare institutes, hospitals, and institutes and raising clinical outcomes.
Want to Explore More on this Business Research Study- https://www.alliedmarketresearch.com/request-sample/5241
Melissa Dempsey, the CGTA Chairwoman and Genetic Counselor at Illumin, highlighted that the alliance believes in clinical utility of genetic testing in cardiology and aims to create awareness to increase clinical outcomes. Genetic testing in cardiology can determine at-risk patients for several cardiac conditions including cardiomyopathies, arrhythmias, and congenital heart malformations.
“Predictive & Presymptomatic testing segment is expected to witness a decline as genetic counselors are largely unable to see patients in person, doctors are not available for counselling and laboratories are not able to run the tests due to COVID-19 pandemic.”
Determining the risks related to development of heart condition, the researchers from Arizona, the U.S. began a trial. In this trial, they utilize genetic testing for determining men and women at the risk of heart disease with the help of their DNA makeup. If the trial gives successful results, this method can be utilized across the world to determine the patients with potential heart conditions. Researchers from Arizona hospital have been conducting a trial in which they will collect DNA samples from men and women aged between 40 and 60. These samples will be analyzed to determine if they contain genetic markers that may lead to heart disease.